Belgian drugmaker UCB, BoneBot’s developer, said licensing it out to ImageBiopsy could see it brought into clinical practice by 2023, according to the report.
The AI focuses on identifying small vertebral compression fractures and distinguishing them from other problems such as vertebral degeneration. It will be integrated into ImageBiopsy’s existing AI-based platform, according to pharmaphorum.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
